Liver fat contents in type 2 diabetic patients with nonalcoholic fatty liver disease under metformin treatment
WU Guo-ting
Abstract
WU Guo-ting
Abstract
Objective To investigate the change of liver fat contents in type 2 diabetic patients with non-alcoholic fatty liver disease(NAFLD) under metformin treatment.Methods Fifty patients with type 2 diabetes mellitus(T2DM) and NAFLD were assigned to receive metformin treatment(groupA,n=25) or non-metformin treatment(group B,n=25).The intrahepatic fat contents were examined by MRS;the mass of fat peak/the mass of fat peak + the mass of water peak 5.5% was diagnosed as NAFLD.Results Twenty four cases in each group were completed with treatment and followed up.There were no significant differences in liver fat accumulation between two groups(P0.05);however,after treatment the TC,BMI,FPG,HbA1c and TG levels in group A were significantly lower than those in group B.Conclusion Metformin can improve glycometabolism in T2DM patients with NAFLD.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the change of liver fat contents in type 2 diabetic patients with non-alcoholic fatty liver disease(NAFLD) under metformin treatment.Methods Fifty patients with type 2 diabetes mellitus(T2DM) and NAFLD were assigned to receive metformin treatment(groupA,n=25) or non-metformin treatment(group B,n=25).The intrahepatic fat contents were examined by MRS;the mass of fat peak/the mass of fat peak + the mass of water peak 5.5% was diagnosed as NAFLD.Results Twenty four cases in each group were completed with treatment and followed up.There were no significant differences in liver fat accumulation between two groups(P0.05);however,after treatment the TC,BMI,FPG,HbA1c and TG levels in group A were significantly lower than those in group B.Conclusion Metformin can improve glycometabolism in T2DM patients with NAFLD.
Key concepts: Metformin, Nonalcoholic fatty liver disease, Internal medicine, Medicine, Fatty liver, Gastroenterology, Type 2 Diabetes Mellitus, Type 2 diabetes